1. Home
  2. FINV vs ARDX Comparison

FINV vs ARDX Comparison

Compare FINV & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FinVolution Group

FINV

FinVolution Group

N/A

Current Price

$2.85

Market Cap

668.1M

Sector

Finance

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$3.11

Market Cap

724.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FINV
ARDX
Founded
2007
2007
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
668.1M
724.0M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
FINV
ARDX
Price
$2.85
$3.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
11
Target Price
$5.62
★ $12.50
AVG Volume (30 Days)
788.1K
★ 4.6M
Earning Date
11-25-2026
11-03-2026
Dividend Yield
★ 11.25%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,607,000.00
Revenue This Year
N/A
$18.39
Revenue Next Year
N/A
$26.08
P/E Ratio
$3.87
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.66
$2.80
52 Week High
$6.39
$8.40

Technical Indicators

Market Signals
Indicator
FINV
ARDX
Relative Strength Index (RSI) 44.50 48.00
Support Level N/A $2.96
Resistance Level $3.06 $3.38
Average True Range (ATR) 0.13 0.16
MACD 0.00 0.03
Stochastic Oscillator 48.62 49.18

Price Performance

Historical Comparison
FINV
ARDX

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: